PNEUMONIX WINS VENTUREWELL E-TEAM PHASE II GRANT FOR PREVENTING PTX

Meet PneumoNIX team at the VentureWell E-team workshop in Boston from Jan. 31st - Feb. 2nd

Recent Posts

PneumoNIX has received follow-on Phase II grant from the NSF SBIR to continue the development of their proprietary technology.

PneumoNIX Medical, a Baltimore-based medtech company focused on preventing complications associated with soft tissue biopsies, announced...

PneumoNIX Medical was selected to present to Johns Hopkins Hospital, Maryland Department of Commerce and Technology Development...